Exmceuticals Inc
CNSX:EXM
Exmceuticals Inc
Research & Development
Exmceuticals Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Exmceuticals Inc
CNSX:EXM
|
Research & Development
-CA$39.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$629m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Research & Development
-CA$478k
|
CAGR 3-Years
44%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$4.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Research & Development
-CA$27.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
Exmceuticals Inc
Glance View
EXMceuticals, Inc. is a pharmaceutical biosciences company, which engages in producing therapeutic cannabis. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-01-31. The firm operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.
See Also
What is Exmceuticals Inc's Research & Development?
Research & Development
-39.6k
CAD
Based on the financial report for Jun 30, 2020, Exmceuticals Inc's Research & Development amounts to -39.6k CAD.
What is Exmceuticals Inc's Research & Development growth rate?
Research & Development CAGR 1Y
94%
Over the last year, the Research & Development growth was 94%.